http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-76692-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a8cca3f790ee98301fb72db22956ede
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe61309cfd154d2803c19b421db0b292
publicationDate 2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-76692-U
titleOfInvention A method for predicting the antithrombotic effect of ramipril in patients with arterial hypertension in combination with type II diabetes mellitus depending on the polymorphism of the endothelial NO synthase-3 gene
abstract A method for predicting the antithrombotic effect of ramipril in patients with arterial hypertension in combination with type II diabetes mellitus depending on the polymorphism of the endothelial NO synthase-3 gene, in which the dynamics of protein C is evaluated after 6 months of controlled treatment and the presence of the C → T mutation at position 786 of the gene is taken into account endothelial NO synthase-3.
priorityDate 2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535046
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2541750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID120093082
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100533464
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19131
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID542269

Total number of triples: 21.